Stock BCEL ATRECA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Atreca, Inc.

Equities

BCEL

US04965G1094

Market Closed - OTC Markets
Other stock markets
 01:04:26 27/04/2024 am IST 		5-day change 1st Jan Change
0.08 USD -6.43% Intraday chart for Atreca, Inc. +3.90% -39.39%
17/04 North American Morning Briefing : Stock Futures -2- DJ
10/04 North American Morning Briefing : Traders Await -2- DJ

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Atreca, Inc. Announces Board Resignations
Immunome Signs Asset Purchase Agreement for Acquisition of Antibody-Related Assets From Atreca
Atreca, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Atreca, Inc. to Continue Exploring Strategic Alternatives
Investors Remain Cautious Over Fed Moves, Setting Wall Street Up for Lower Open
Top Premarket Gainers
Atreca to Terminate Lease on California Headquarters; Chief Financial Officer Resigns
Atreca, Inc. Appoints Rick Ruiz as the Principal Accounting Officer
Atreca, Inc. Reduces its Workforce by Approximately 40%
Atreca, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Atreca, Inc. Presents Data from Ongoing Phase 1b Study of ATRC-101 in Patients with Select Advanced Solid Tumors During Oral Abstract
Atreca, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Atreca, Inc. Reports Additional Data from Ongoing Phase 1b Trial
Atreca, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022
Atreca, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Atreca, Xencor to Develop T-Cell Engaging Bispecific Antibody Targeting Solid Tumors
Atreca, Inc. and Xencor, Inc. to Develop T Cell Engaging Bispecific Antibody Directed Against Novel Solid Tumor Target
Atreca, Inc. Announces the Appointment of Philippe Bishop, MD, as Chief Medical Officer
Atreca, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Atreca, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BCEL Stock
  4. News Atreca, Inc.
  5. Other languages